Suppression of experimental allergic encephalomyelitis in the Lewis rat by the matrix metalloproteinase inhibitor Ro31-9790

This publication has 23 references indexed in Scilit:

• Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteases.
  Journal of Clinical Investigation, 1994
• Variable susceptibility of Lewis rats to experimental autoimmune encephalomyelitis
  Journal of Neuroimmunology, 1994
• Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein
  Journal of Neuroscience Research, 1993
• Leukocyte Gelatinase B Cleavage Releases Encephalitogens from Human Myelin Basic Protein
  Biochemical and Biophysical Research Communications, 1993
• Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) is induced in rabbit articular chondrocytes by cotreatment with interleukin 1β and a protein kinase C activator
  Experimental Cell Research, 1992
• Hypothalamic noradrenergic pathways exert an influence on neuroendocrine and clinical status in experimental autoimmune encephalomyelitis
  Brain, Behavior, and Immunity, 1991
• Purification and identification of 91‐kDa neutrophil gelatinase
  European Journal of Biochemistry, 1991
• Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.
  The Journal of Experimental Medicine, 1985
• Proteinase inhibitors suppress the development of experimental allergic encephalomyelitis
  Nature, 1980
• Degradation of myelin basic protein by cerebrospinal fluid: Preservation of antigenic determinants under physiological conditions
  Annals of Neurology, 1979